Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen

Margaret Lartey, Kwamena W. Sagoe, Hongmei Yang, Ernest Kenu, Fafa Xexemeku, Joseph Oliver-Commey, Vincent Boima, Markafui Seshie, Augustine Sagoe, Julius A.A. Mingle, Timothy P. Flanigan, Hulin Wu, Awewura Kwara

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P >.05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.

Original languageEnglish
Pages (from-to)547-550
Number of pages4
JournalClinical Infectious Diseases
Volume52
Issue number4
DOIs
Publication statusPublished - 15 Feb 2011

Fingerprint

Dive into the research topics of 'Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an efavirenz-based regimen'. Together they form a unique fingerprint.

Cite this